Fujiyama, Shunichiro
Akuta, Norio
Sezaki, Hitomi
Kobayashi, Mariko
Kawamura, Yusuke
Hosaka, Tetsuya
Kobayashi, Masahiro
Saitoh, Satoshi
Suzuki, Fumitaka
Suzuki, Yoshiyuki
Arase, Yasuji
Ikeda, Kenji
Kumada, Hiromitsu
Article History
Received: 6 November 2020
Accepted: 14 April 2021
First Online: 23 April 2021
Declarations
:
: The study was conducted in compliance with the International Conference on Harmonization guidelines for Good Clinical Practice (E6) and the 2013 Declaration of Helsinki. The protocol was approved by the institutional review board at Toranomon Hospital (number; 1166 and 1891). Written informed consent was provided by all patients prior to liver biopsy.
: Not applicable.
: (1) Hiromitsu Kumada has received honoraria from MSD K.K., Gilead Sciences, AbbVie Inc., Eisai Co., Ltd, and Dainippon Sumitomo Pharma. (2) Norio Akuta has received honoraria from AbbVie Inc and Gilead Sciences. (3) Yasuji Arase has received honorarium from AbbVie Inc. (4) Masahiro Kobayashi has received honoraria from Eisai Co., Ltd. (5) Yusuke Kawamura has received honoraria from Eisai Co., Ltd. All other authors declare no conflict of interest.